Rick Pollack, president and CEO of American Hospital Association, and Marilyn Tavenner president and CEO of America's Health Insurance Plans, told attendees at a panel hosted by the Nashville Health Care Council to expect a contentious round of health care reform debate as federal lawmakers try to find consensus on how to replace or repair the Affordable Care Act. (Photo: Credit/Donn Jones, Donn Jones for Nashville Health Care Council)Don't expect reform of the Affordable Care Act to be tabled or resolved any time soon. Debate over how to replace or repair the controversial federal health law is projected to run through the end of the year and probably into 2018 — and it certainly won't be wrapped up in the next six months, according to leaders of two of the county's weightiest health care organizations who spoke Thursday on a panel hosted by the Nashville Health Care Council in Cool Springs. Buzz60 3 of 9 CLOSE Skip in Skip x Embed x Share VIDEOS: OBAMACARE, HEALTHCARE EXCHANGE ISSUES Haslam: States need more control over health care | 1:17 Gov. But in what Pollack called a traffic jam of issues, both he and Tavenner agreed that Congress should move on actions to stabilize the individual health insurance exchange for 2018.
Health care leaders gather in Washington
WASHINGTON — Leaders across the health care continuum on Thursday gathered in Washington, D.C. to offer perspectives on efforts currently underway to move the healthcare system toward one that rewards innovation, delivers better quality and puts the patient at the center of the value equation. However, panelists agreed the opportunity to more broadly employ such approaches hinges on reforming outdated laws and regulations that are making it more difficult to pay for medicines based on the value they provide to patients and the health care system. The meeting was convened by The Value Collaborative, an initiative of America's biopharmaceutical companies, in partnership with Morning Consult. "Biopharmaceutical science is advancing faster than ever before, and we need a reimbursement system as innovative as the medicines," said Stephen J. Ubl, president and CEO, Pharmaceutical Research and Manufacturers of America. An archive of the event can be found here.collected by :Lucy William
No comments:
Post a Comment